Rise Reforming bets modular biogas-to-DME units can beat centralized chemical plants

Rise Reforming sells small modular chemical plants that convert biogas — methane and CO2 from wastewater, farms and landfills — into dimethyl ether (DME) and methanol, starting with a pilot at a Chicagoland wastewater plant that the company says will be the first wastewater biogas-to-methanol demo in the Americas.

Stranded biogas at wastewater plants can be reformed on-site into chemicals undercutting centralized fossil production, with modular units and offtakes carrying the risk.

More than $1.7M raised as of July 2026, per the University of Chicago PME article, including Y Combinator batch funding; the company reports supply agreements and LOIs with biogas producers plus offtake agreements and LOIs for DME and methanol.

George Rose, Lucas Zubillaga and Jona van Oord met as University of Chicago molecular-engineering undergraduates; the company grew out of a 2023 dining-hall conversation about methane pollution, was honed through PME's engineering-design capstone and the Polsky Center, and was founded in 2024. The original plan converted plastic waste into chemicals, but in 2025 the team pivoted to biogas, which is already in gas form and removes a whole process step.

Rise Reforming joined Y Combinator's Summer 2026 batch as a four-person Chicago team and broke ground on a pilot at a Chicagoland wastewater treatment plant, described as the first wastewater biogas-to-methanol demonstration in the Americas, expected online in 2027. The Launch HN thread on 2026-07-27 pressed the founders on catalyst reliability, gas cleanup, power draw and why biogas rather than flared natural gas; the founders argued that biogas gives roughly 90% lower carbon footprint, runs 24/7 at consistent composition, and that their process is more efficient with CO2, which the waste stream is rich in.

The pivot cut real process risk: plastic waste has to be gasified before reforming, while biogas arrives already gaseous, which removes a step and shortens the path to a first plant.

Small-site economics open a wedge incumbents ignore: units viable near 45 SCFM let the team start at wastewater plants that flare the most, not chase giant contracts.

DME first, methanol second is a staged market entry: aerosol propellants and propane additive are concrete buyers, while the commodity methanol market is the scale prize once the technology is proven.

The Launch HN thread was the stress test: 85 points of questions on catalyst reliability, gas cleanup and power draw exposed the risks to retire first.

Pick a feedstock that removes a process step and a market you can enter small: DME's concrete buyers let a four-person team start before methanol economics prove out.

As of 2026-09-06 Rise Reforming is an active four-person YC Summer 2026 company in Chicago. It has raised more than $1.7M, holds supply and offtake LOIs on both sides of the market, and is building its first pilot at a Chicagoland wastewater plant, expected online in 2027. Cost and carbon claims — competitive with fossil DME and 'cheapest green methanol' — come from the founders' own process simulations, and the commercial test of whether modular biogas reforming can actually undercut centralized chemical production is still ahead.